UK Markets closed

Bath & Body Works, Inc. (BBWI)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
35.51+0.22 (+0.62%)
At close: 04:03PM EDT
35.48 -0.03 (-0.08%)
After hours: 04:12PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.71
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 382.00
52-week low 325.75
50-day moving average 337.32
200-day moving average 344.93

Share statistics

Avg vol (3-month) 34.03M
Avg vol (10-day) 32.91M
Shares outstanding 5257.72M
Implied shares outstanding 6N/A
Float 8186.46M
% held by insiders 12.62%
% held by institutions 1103.31%
Shares short (14 Jul 2022) 418.62M
Short ratio (14 Jul 2022) 43.51
Short % of float (14 Jul 2022) 49.32%
Short % of shares outstanding (14 Jul 2022) 48.14%
Shares short (prior month 14 Jun 2022) 420.61M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 42.25%
Trailing annual dividend rate 30.30
Trailing annual dividend yield 30.85%
5-year average dividend yield 4N/A
Payout ratio 415.26%
Dividend date 301 Sept 2022
Ex-dividend date 401 Jun 2022
Last split factor 22:1
Last split date 330 May 2000

Financial highlights

Fiscal year

Fiscal year ends 28 Jan 2022
Most-recent quarter (mrq)29 Apr 2022


Profit margin 15.40%
Operating margin (ttm)24.83%

Management effectiveness

Return on assets (ttm)15.84%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)7.86B
Revenue per share (ttm)30.33
Quarterly revenue growth (yoy)-1.40%
Gross profit (ttm)3.85B
Net income avi to common (ttm)1.14B
Diluted EPS (ttm)5.74
Quarterly earnings growth (yoy)-44.00%

Balance sheet

Total cash (mrq)651M
Total cash per share (mrq)2.85
Total debt (mrq)6.04B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.41
Book value per share (mrq)-6.45

Cash flow statement

Operating cash flow (ttm)1.31B
Levered free cash flow (ttm)715.12M